NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 69 filers reported holding NEOGENOMICS INC in Q2 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $535,022,000 | +2.9% | 66,545 | -13.7% | 0.18% | +11.4% |
| Q1 2016 | $519,957,000 | -57.7% | 77,145 | -50.6% | 0.17% | -66.0% |
| Q4 2015 | $1,227,862,000 | +72.3% | 156,018 | +25.4% | 0.49% | +84.8% |
| Q3 2015 | $712,652,000 | +64.3% | 124,372 | +55.1% | 0.26% | +67.1% |
| Q2 2015 | $433,882,000 | +11.3% | 80,200 | -3.9% | 0.16% | +0.6% |
| Q1 2015 | $389,838,000 | +46.4% | 83,477 | +30.7% | 0.16% | +84.7% |
| Q4 2014 | $266,250,000 | -71.7% | 63,849 | -64.7% | 0.08% | -75.7% |
| Q3 2014 | $941,317,000 | +144273.8% | 180,675 | -8.0% | 0.35% | +50.2% |
| Q2 2014 | $652,000 | – | 196,311 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |